Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Maurizio Zangari

Concepts (495)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
148
2024
2954
10.400
Why?
Thalidomide
33
2016
377
3.060
Why?
Boronic Acids
17
2013
182
2.920
Why?
Pyrazines
17
2013
187
2.920
Why?
Hematopoietic Stem Cell Transplantation
22
2024
567
2.100
Why?
Bone Marrow
17
2022
363
1.950
Why?
Venous Thrombosis
8
2009
90
1.760
Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
990
1.740
Why?
Paraproteinemias
7
2022
72
1.660
Why?
Angiogenesis Inhibitors
12
2009
188
1.570
Why?
Humans
162
2024
50208
1.420
Why?
Protease Inhibitors
7
2011
58
1.390
Why?
Chromosomes, Human, Pair 1
7
2023
93
1.350
Why?
Proteasome Inhibitors
6
2016
104
1.300
Why?
Prognosis
40
2024
1954
1.230
Why?
Middle Aged
66
2024
12206
1.210
Why?
Antineoplastic Agents
20
2024
1186
1.200
Why?
Aged
63
2024
9405
1.200
Why?
Alkaline Phosphatase
7
2020
95
1.190
Why?
Neoplasm, Residual
6
2022
165
1.160
Why?
Transplantation, Autologous
30
2024
469
1.140
Why?
Thrombosis
6
2013
248
1.080
Why?
Bone Remodeling
3
2016
149
1.070
Why?
Bone Diseases
2
2021
99
1.050
Why?
Antibodies, Bispecific
5
2024
69
1.030
Why?
Osteogenesis
4
2018
353
0.960
Why?
Male
73
2024
25399
0.960
Why?
Female
72
2024
26635
0.940
Why?
Immunologic Factors
5
2016
114
0.930
Why?
Gene Expression Profiling
21
2023
1037
0.900
Why?
Anticoagulants
6
2009
253
0.860
Why?
Peripheral Blood Stem Cell Transplantation
6
2012
53
0.850
Why?
Melphalan
12
2016
174
0.840
Why?
Neoplasms, Plasma Cell
4
2024
37
0.830
Why?
Activated Protein C Resistance
4
2011
10
0.810
Why?
Monoclonal Gammopathy of Undetermined Significance
8
2024
115
0.790
Why?
Parathyroid Hormone
4
2018
147
0.770
Why?
Venous Thromboembolism
3
2011
68
0.760
Why?
Antibodies, Monoclonal
4
2022
460
0.750
Why?
Adult
41
2024
13324
0.730
Why?
Durapatite
1
2020
24
0.720
Why?
Disease-Free Survival
21
2019
454
0.690
Why?
Gene Amplification
1
2019
57
0.690
Why?
Survival Rate
21
2020
901
0.680
Why?
Thromboembolism
3
2009
54
0.680
Why?
Neoplasm Proteins
7
2020
324
0.680
Why?
Dexamethasone
14
2024
430
0.670
Why?
Myeloablative Agonists
4
2012
30
0.670
Why?
Retrospective Studies
24
2024
6134
0.630
Why?
Gene Expression Regulation, Neoplastic
12
2021
828
0.630
Why?
Bone and Bones
4
2021
475
0.630
Why?
Factor V
4
2011
11
0.620
Why?
Oligopeptides
3
2018
91
0.620
Why?
Spinal Fractures
1
2018
38
0.620
Why?
Aged, 80 and over
20
2024
3154
0.620
Why?
Thymus Gland
1
2018
41
0.610
Why?
Treatment Outcome
32
2024
5155
0.600
Why?
Stem Cell Transplantation
12
2024
182
0.600
Why?
Parathyroidectomy
1
2018
45
0.600
Why?
Thyroidectomy
1
2018
60
0.590
Why?
Translocation, Genetic
8
2021
264
0.590
Why?
Disease Progression
16
2023
831
0.590
Why?
Clinical Trials as Topic
9
2022
466
0.580
Why?
Chromosome Aberrations
11
2023
297
0.570
Why?
Calcification, Physiologic
1
2017
41
0.570
Why?
Follow-Up Studies
22
2024
2190
0.560
Why?
Pelvis
1
2017
67
0.560
Why?
Osteoblasts
6
2020
450
0.550
Why?
Thrombophilia
4
2009
18
0.540
Why?
Risk Factors
22
2021
3629
0.530
Why?
Survival Analysis
13
2021
666
0.520
Why?
Tumor Microenvironment
5
2024
233
0.520
Why?
Chromosome Deletion
6
2023
140
0.500
Why?
Drug Resistance, Neoplasm
7
2015
314
0.500
Why?
Plasma Cells
9
2023
223
0.500
Why?
B-Cell Maturation Antigen
6
2024
91
0.480
Why?
Neoplasms
3
2009
1249
0.480
Why?
Animals
19
2024
13246
0.480
Why?
Transplantation Conditioning
7
2019
84
0.470
Why?
Neoplasm Recurrence, Local
7
2024
613
0.460
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.450
Why?
Polycythemia Vera
1
2013
6
0.440
Why?
Hemostasis
3
2008
55
0.430
Why?
Neovascularization, Pathologic
4
2009
162
0.420
Why?
Mutation
6
2022
1294
0.410
Why?
Combined Modality Therapy
17
2024
636
0.410
Why?
Neutropenia
2
2023
115
0.400
Why?
Hematopoietic Stem Cells
2
2012
184
0.380
Why?
Bone Neoplasms
2
2010
183
0.370
Why?
Amyloidosis
3
2009
81
0.360
Why?
Evolution, Molecular
2
2021
99
0.360
Why?
Doxorubicin
7
2009
239
0.360
Why?
Immunotherapy, Adoptive
4
2024
157
0.350
Why?
Anti-Anxiety Agents
1
2009
35
0.340
Why?
Mice
11
2024
5759
0.340
Why?
In Situ Hybridization, Fluorescence
7
2023
259
0.330
Why?
Kaplan-Meier Estimate
10
2019
465
0.330
Why?
Hemorrhagic Disorders
1
2009
5
0.330
Why?
Cryoglobulinemia
1
2008
13
0.320
Why?
Biopsy, Needle
1
2009
181
0.320
Why?
Pain
2
2009
381
0.320
Why?
Analgesics
1
2009
101
0.310
Why?
Recurrence
11
2024
662
0.310
Why?
Pulmonary Embolism
1
2009
97
0.310
Why?
Collagen
2
2020
207
0.310
Why?
Risk Assessment
7
2023
1262
0.300
Why?
Hematologic Neoplasms
2
2022
99
0.290
Why?
Cell Line, Tumor
4
2023
1416
0.290
Why?
Farnesyltranstransferase
1
2006
5
0.290
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
32
0.280
Why?
Osteolysis
2
2022
75
0.280
Why?
Waldenstrom Macroglobulinemia
2
2022
40
0.280
Why?
Pyrroles
2
2004
69
0.280
Why?
Risk
4
2014
324
0.280
Why?
Cell Differentiation
4
2022
650
0.270
Why?
Neoplasms, Second Primary
2
2024
78
0.270
Why?
Sirolimus
1
2006
62
0.270
Why?
Cell Proliferation
8
2023
1013
0.270
Why?
Time Factors
11
2021
2922
0.270
Why?
Logistic Models
5
2018
889
0.270
Why?
Signal Transduction
6
2021
1622
0.260
Why?
Chromosomes, Human, Pair 17
2
2017
36
0.260
Why?
Fluorodeoxyglucose F18
4
2021
194
0.240
Why?
Plasmacytoma
2
2020
42
0.240
Why?
Enoxaparin
1
2004
27
0.240
Why?
Polycomb Repressive Complex 2
2
2021
47
0.240
Why?
Remission Induction
10
2021
207
0.240
Why?
Indoles
2
2004
278
0.230
Why?
Vascular Endothelial Growth Factor A
2
2004
202
0.230
Why?
Prospective Studies
9
2019
2379
0.220
Why?
Blood Coagulation
1
2003
56
0.220
Why?
Positron-Emission Tomography
3
2022
294
0.210
Why?
Bone Resorption
2
2022
302
0.210
Why?
Immunoglobulin Light Chains
2
2017
82
0.210
Why?
Proto-Oncogene Proteins B-raf
2
2020
79
0.210
Why?
Randomized Controlled Trials as Topic
3
2012
550
0.200
Why?
Hematopoietic Stem Cell Mobilization
3
2008
57
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
Drug Approval
1
2022
47
0.200
Why?
Cell Cycle
2
2021
232
0.200
Why?
Hemorrhage
3
2009
197
0.200
Why?
Chromosomal Instability
2
2019
16
0.200
Why?
Lymphoma, B-Cell
1
2022
63
0.200
Why?
Epigenomics
1
2021
68
0.190
Why?
Chromosomes, Human, Pair 13
5
2008
38
0.190
Why?
Patient Participation
1
2022
66
0.190
Why?
SOXC Transcription Factors
1
2021
13
0.190
Why?
Arkansas
5
2021
1985
0.190
Why?
T-Lymphocytes
4
2024
339
0.190
Why?
Diffusion Magnetic Resonance Imaging
2
2019
124
0.190
Why?
Odontoblasts
1
2020
4
0.180
Why?
Calcium Phosphates
1
2020
5
0.180
Why?
HL-60 Cells
1
2020
18
0.180
Why?
U937 Cells
1
2020
14
0.180
Why?
Etoposide
5
2009
72
0.180
Why?
K562 Cells
1
2020
42
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Kidney Diseases
2
2020
214
0.180
Why?
NIH 3T3 Cells
1
2020
52
0.180
Why?
Mammals
1
2020
58
0.180
Why?
MCF-7 Cells
1
2020
69
0.180
Why?
Practice Guidelines as Topic
1
2023
449
0.180
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
Why?
Protein C
2
2011
18
0.180
Why?
Leukemia, Plasma Cell
1
2020
33
0.180
Why?
Myelodysplastic Syndromes
3
2007
81
0.170
Why?
beta 2-Microglobulin
5
2008
38
0.170
Why?
HEK293 Cells
1
2020
224
0.170
Why?
Busulfan
1
2019
19
0.170
Why?
Cisplatin
6
2009
278
0.170
Why?
HeLa Cells
1
2020
260
0.170
Why?
Atrial Fibrillation
1
2022
183
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
Epigenesis, Genetic
2
2020
378
0.170
Why?
Imaging, Three-Dimensional
2
2017
153
0.160
Why?
Genome-Wide Association Study
1
2020
166
0.160
Why?
Healthcare Disparities
1
2022
268
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Fractures, Compression
1
2018
17
0.160
Why?
Predictive Value of Tests
4
2009
905
0.160
Why?
Spleen
1
2019
172
0.160
Why?
Fibrinolysis
2
2009
5
0.160
Why?
Phosphotransferases
1
2018
16
0.160
Why?
Genomic Instability
2
2016
93
0.150
Why?
Blood Coagulation Factors
2
2009
17
0.150
Why?
Antineoplastic Agents, Alkylating
6
2008
74
0.150
Why?
Cytokines
3
2007
613
0.150
Why?
Bacteremia
1
2019
92
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Gene Rearrangement
1
2018
74
0.150
Why?
Cell Line
1
2020
1021
0.150
Why?
Cluster Analysis
4
2012
235
0.150
Why?
Metaphase
4
2016
44
0.150
Why?
Hexokinase
1
2017
17
0.150
Why?
Heparin, Low-Molecular-Weight
2
2007
20
0.140
Why?
Ultrasonography, Doppler
2
2007
42
0.140
Why?
Renal Insufficiency
4
2010
109
0.140
Why?
Fibrinolytic Agents
2
2007
125
0.130
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Calcium
1
2018
400
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.130
Why?
Tumor Burden
3
2020
131
0.130
Why?
Tumor Suppressor Protein p53
1
2017
203
0.130
Why?
Gene Expression
1
2018
609
0.130
Why?
Disease Models, Animal
4
2016
1458
0.130
Why?
Genes, Neoplasm
1
2015
30
0.130
Why?
Multivariate Analysis
7
2021
581
0.130
Why?
Immunotherapy
2
2016
240
0.130
Why?
Bone Marrow Transplantation
4
2022
116
0.130
Why?
Polymorphism, Single Nucleotide
2
2020
485
0.130
Why?
Gene Dosage
1
2015
78
0.120
Why?
Salvage Therapy
6
2006
139
0.120
Why?
Incidence
2
2009
1006
0.120
Why?
Algorithms
1
2018
618
0.120
Why?
Osteoclasts
3
2022
428
0.110
Why?
Cystatin M
2
2024
20
0.110
Why?
Case-Control Studies
4
2011
1126
0.110
Why?
Altitude
1
2013
16
0.110
Why?
Chromosomes, Human, Pair 11
3
2020
54
0.110
Why?
Janus Kinase 2
1
2013
26
0.110
Why?
Cross-Sectional Studies
3
2023
1554
0.110
Why?
Tomography, X-Ray Computed
2
2017
1161
0.110
Why?
STAT3 Transcription Factor
2
2010
81
0.110
Why?
Bone Density Conservation Agents
2
2010
74
0.110
Why?
Protein-Tyrosine Kinases
3
2018
95
0.110
Why?
Models, Biological
1
2016
723
0.110
Why?
Creatinine
2
2010
141
0.100
Why?
Mice, Inbred C57BL
1
2018
1819
0.100
Why?
Cytogenetic Analysis
6
2014
82
0.100
Why?
Viremia
1
2012
22
0.100
Why?
Clone Cells
2
2023
78
0.100
Why?
Cytomegalovirus Infections
1
2012
35
0.100
Why?
Models, Genetic
2
2016
170
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
44
0.100
Why?
Clinical Trials, Phase III as Topic
1
2012
43
0.100
Why?
Viper Venoms
1
2011
7
0.100
Why?
Drug Evaluation, Preclinical
1
2012
143
0.100
Why?
Epidemiologic Methods
2
2008
49
0.100
Why?
NF-kappa B
2
2018
315
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
Why?
Arsenicals
1
2010
14
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Oxides
1
2010
18
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Granulocyte Colony-Stimulating Factor
2
2008
61
0.090
Why?
Hypercalcemia
1
2010
33
0.090
Why?
Transplantation, Homologous
4
2003
138
0.090
Why?
Cyclophosphamide
4
2003
166
0.090
Why?
Antineoplastic Agents, Hormonal
2
2007
48
0.090
Why?
Janus Kinase 1
1
2010
17
0.090
Why?
Anemia
1
2010
67
0.090
Why?
MAP Kinase Kinase 1
1
2010
23
0.090
Why?
Administration, Oral
2
2009
434
0.090
Why?
Cyclin-Dependent Kinases
1
2010
28
0.090
Why?
Proteinuria
1
2010
39
0.090
Why?
Alleles
2
2021
251
0.090
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.090
Why?
Genomics
2
2023
285
0.090
Why?
Diphosphonates
1
2010
90
0.090
Why?
Lorazepam
1
2009
12
0.080
Why?
Anesthesia, Local
1
2009
15
0.080
Why?
Hyperhomocysteinemia
1
2009
29
0.080
Why?
Receptors, Retinoic Acid
1
2009
23
0.080
Why?
Oxycodone
1
2009
27
0.080
Why?
Dose-Response Relationship, Drug
3
2008
1378
0.080
Why?
Prednisone
1
2009
101
0.080
Why?
Tretinoin
1
2009
53
0.080
Why?
Hemostatic Techniques
1
2009
28
0.080
Why?
Plasma Exchange
1
2009
23
0.080
Why?
Histones
2
2021
313
0.080
Why?
Vasculitis
1
2008
29
0.080
Why?
Vincristine
3
2003
88
0.080
Why?
Syndecan-1
3
2021
72
0.080
Why?
Transcription Factors
2
2023
564
0.080
Why?
Biopsy
3
2018
590
0.080
Why?
Drug Therapy, Combination
1
2009
381
0.080
Why?
DNA Copy Number Variations
2
2021
110
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Carrier Proteins
1
2010
306
0.080
Why?
Bone Development
1
2009
64
0.080
Why?
Radiopharmaceuticals
2
2021
208
0.080
Why?
Pain Measurement
1
2009
240
0.080
Why?
Staphylococcal Infections
2
2019
269
0.080
Why?
Platelet Aggregation
1
2008
71
0.080
Why?
Thrombocytopenia
1
2009
84
0.080
Why?
Double-Blind Method
1
2009
688
0.080
Why?
Brain Diseases, Metabolic
1
2007
5
0.070
Why?
Phlebography
1
2007
60
0.070
Why?
Hyperammonemia
1
2007
18
0.070
Why?
Myeloma Proteins
1
2007
24
0.070
Why?
Antimetabolites
1
2006
13
0.070
Why?
Chi-Square Distribution
1
2007
278
0.070
Why?
Cell Communication
2
2023
69
0.070
Why?
Transcriptome
2
2020
320
0.070
Why?
Partial Thromboplastin Time
1
2006
12
0.070
Why?
Magnetic Resonance Imaging
4
2007
1541
0.070
Why?
Osteoprotegerin
1
2006
52
0.070
Why?
Heterozygote
1
2006
81
0.070
Why?
Acetaminophen
1
2009
283
0.070
Why?
Antibiotics, Antineoplastic
1
2006
81
0.070
Why?
Gastrointestinal Neoplasms
1
2006
44
0.070
Why?
Models, Statistical
1
2007
224
0.070
Why?
Pilot Projects
1
2008
697
0.070
Why?
Age Factors
3
2005
1092
0.060
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Neovascularization, Physiologic
1
2005
68
0.060
Why?
Apoptosis
1
2010
1112
0.060
Why?
Syndrome
2
2019
238
0.060
Why?
Gene Deletion
2
2003
270
0.060
Why?
Killer Cells, Natural
1
2024
107
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Glucuronidase
1
2003
46
0.060
Why?
Demography
1
2024
92
0.060
Why?
Myeloid Progenitor Cells
1
2023
18
0.060
Why?
X-Ray Microtomography
1
2024
77
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
128
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
53
0.060
Why?
DNA Methylation
2
2020
550
0.060
Why?
Immunosuppressive Agents
1
2005
222
0.060
Why?
DNA, Neoplasm
2
2020
147
0.060
Why?
Antibodies
1
2024
154
0.060
Why?
Discitis
1
2003
9
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2006
411
0.050
Why?
Myeloproliferative Disorders
1
2003
28
0.050
Why?
Antigens, CD34
1
2003
66
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Platelet Count
3
2008
72
0.050
Why?
Tumor Cells, Cultured
3
2010
468
0.050
Why?
Patients
1
2022
49
0.050
Why?
Geography
1
2022
60
0.050
Why?
Rats
1
2009
3299
0.050
Why?
Leukemia, Myeloid
1
2002
43
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Receptors, Antigen, T-Cell
1
2022
51
0.050
Why?
Drug Interactions
1
2002
208
0.050
Why?
Patient Selection
1
2023
253
0.050
Why?
Chromosome Disorders
1
2002
35
0.050
Why?
United States Food and Drug Administration
1
2022
91
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Enzyme Inhibitors
1
2004
386
0.050
Why?
Hypothyroidism
1
2002
54
0.050
Why?
Central Nervous System Neoplasms
1
2002
64
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Cohort Studies
2
2020
1422
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.050
Why?
Chromatin
1
2021
152
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
225
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Aneuploidy
1
2020
16
0.050
Why?
Pyrimidines
1
2022
193
0.050
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.050
Why?
Endothelium, Vascular
1
2002
254
0.050
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.050
Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.050
Why?
Histone Code
1
2020
32
0.050
Why?
Cyclin D1
1
2020
56
0.050
Why?
ras Proteins
1
2020
64
0.050
Why?
Genome, Human
1
2021
111
0.050
Why?
Longitudinal Studies
2
2016
695
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Protein Kinase Inhibitors
1
2022
206
0.040
Why?
Transcriptional Elongation Factors
1
2020
18
0.040
Why?
Postoperative Complications
1
2007
996
0.040
Why?
Genetic Loci
1
2020
49
0.040
Why?
Health Status Disparities
1
2022
194
0.040
Why?
RNA, Messenger
3
2010
1108
0.040
Why?
Genetic Variation
1
2020
213
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
170
0.040
Why?
Neoplastic Stem Cells
2
2015
103
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
26
0.040
Why?
Computational Biology
1
2020
216
0.040
Why?
Pseudomonas Infections
1
2019
48
0.040
Why?
Proline
1
2018
30
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
DNA-Binding Proteins
1
2021
428
0.040
Why?
Recombinant Proteins
2
2010
487
0.040
Why?
Fluorescent Dyes
1
2018
106
0.040
Why?
Promoter Regions, Genetic
1
2020
475
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Proteolysis
1
2018
95
0.040
Why?
Oncogene Proteins, Fusion
1
2018
58
0.040
Why?
Extracellular Matrix
1
2018
111
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
Cell Movement
1
2018
249
0.040
Why?
False Positive Reactions
1
2017
62
0.040
Why?
Glomerular Filtration Rate
1
2017
111
0.040
Why?
Amino Acid Sequence
1
2018
586
0.030
Why?
Genetic Predisposition to Disease
1
2020
509
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Cell Survival
2
2010
602
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Mice, SCID
2
2009
176
0.030
Why?
Glycolysis
1
2016
70
0.030
Why?
Chromosome Mapping
2
2006
156
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
140
0.030
Why?
Serum Albumin
2
2008
58
0.030
Why?
Syndecans
2
2006
34
0.030
Why?
Proteoglycans
2
2006
80
0.030
Why?
Drug Monitoring
1
2015
78
0.030
Why?
Cells, Cultured
1
2018
1581
0.030
Why?
Myocardium
1
2017
438
0.030
Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
Why?
Karyotype
1
2014
18
0.030
Why?
Proportional Hazards Models
2
2006
410
0.030
Why?
Membrane Glycoproteins
2
2006
246
0.030
Why?
Transplantation Chimera
2
2003
15
0.030
Why?
Neoplasm Staging
2
2007
738
0.030
Why?
Infusions, Intravenous
2
2003
213
0.030
Why?
RNA Interference
1
2013
179
0.030
Why?
Cytomegalovirus
1
2012
27
0.030
Why?
Viral Load
1
2012
77
0.030
Why?
Virus Activation
1
2012
32
0.030
Why?
Graft vs Host Disease
2
2003
75
0.020
Why?
United States
1
2022
4874
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
22
0.020
Why?
Antiviral Agents
1
2012
173
0.020
Why?
CDC2-CDC28 Kinases
1
2010
12
0.020
Why?
Femur
1
2010
133
0.020
Why?
Long-Term Care
1
2010
52
0.020
Why?
Peripheral Nervous System Diseases
1
2010
57
0.020
Why?
RNA, Small Interfering
1
2010
215
0.020
Why?
Down-Regulation
1
2010
349
0.020
Why?
Bone Diseases, Metabolic
1
2010
74
0.020
Why?
Cell Transformation, Neoplastic
1
2010
179
0.020
Why?
Abnormalities, Multiple
1
2010
167
0.020
Why?
Protein Isoforms
1
2009
119
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Ligands
1
2009
205
0.020
Why?
Rabbits
1
2009
374
0.020
Why?
Hemoglobins
1
2008
107
0.020
Why?
Polyethylene Glycols
1
2008
93
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
595
0.020
Why?
Age Distribution
1
2007
168
0.020
Why?
Ammonia
1
2007
72
0.020
Why?
C-Reactive Protein
1
2008
143
0.020
Why?
Diagnosis, Differential
1
2010
1043
0.020
Why?
Mass Screening
1
2010
346
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Blood Proteins
1
2007
82
0.020
Why?
Bone Density
1
2009
379
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Brain
2
2007
1328
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Evidence-Based Medicine
1
2007
247
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
185
0.020
Why?
Radiography
1
2007
491
0.020
Why?
Coculture Techniques
1
2006
146
0.020
Why?
Data Interpretation, Statistical
1
2006
157
0.020
Why?
Neoplasms, Experimental
1
2006
114
0.020
Why?
Interferon-alpha
1
2005
48
0.020
Why?
Survivors
1
2006
125
0.020
Why?
Databases, Factual
1
2007
657
0.010
Why?
Mice, Transgenic
1
2006
550
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Odds Ratio
1
2005
546
0.010
Why?
Trisomy
1
2003
31
0.010
Why?
History, 21st Century
1
2003
55
0.010
Why?
Endothelial Growth Factors
1
2003
9
0.010
Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
Why?
Lymphokines
1
2003
20
0.010
Why?
Fusion Proteins, bcr-abl
1
2003
20
0.010
Why?
Stem Cell Factor
1
2003
7
0.010
Why?
History, 20th Century
1
2003
99
0.010
Why?
Confidence Intervals
1
2003
156
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Probability
1
2003
164
0.010
Why?
Interphase
1
2003
13
0.010
Why?
Diploidy
1
2003
26
0.010
Why?
Leukocyte Count
1
2003
72
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
Interferons
1
2002
38
0.010
Why?
Sex Factors
1
2005
697
0.010
Why?
Cell Count
1
2003
149
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2003
105
0.010
Why?
Drug Administration Schedule
1
2003
377
0.010
Why?
Thyroid Function Tests
1
2002
24
0.010
Why?
Thyrotropin
1
2002
48
0.010
Why?
Prevalence
1
2005
951
0.010
Why?
Tissue Donors
1
2003
113
0.010
Why?
Neutrophils
1
2003
148
0.010
Why?
Fatal Outcome
1
2002
195
0.010
Why?
Cell Division
1
2002
295
0.010
Why?
Reoperation
1
2003
454
0.010
Why?
Acute Disease
1
2002
368
0.010
Why?
Up-Regulation
1
2002
453
0.010
Why?
Anti-Bacterial Agents
1
2003
747
0.010
Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description